Cargando…

Effect of community antiretroviral therapy on treatment outcomes among stable antiretroviral therapy patients in Nigeria: A quasi experimental study

OBJECTIVES: This study evaluates the effect of Community Anti-retroviral Groups on Immunologic, Virologic and clinical outcomes of stable Antiretroviral Therapy patients in Nigeria. METHOD: A cohort of 251 eligible adults (≥18 years) on first-line ART for at least 6 months with CD4 counts >200 ce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dakum, Patrick, Ajav-Nyior, Juliet, Attah, Timothy A., Kayode, Gbenga A., Gomwalk, Asabe, Omuh, Helen, Ibrahim, Halima, Omozuafoh, Mercy, Alash’le, Abimiku, Mensah, Charles, Oluokun, Young, Akolawole, Franca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8075245/ https://www.ncbi.nlm.nih.gov/pubmed/33901199 http://dx.doi.org/10.1371/journal.pone.0250345

Ejemplares similares

Patient Retention and Adherence to Antiretrovirals in a Large Antiretroviral Therapy Program in Nigeria: A Longitudinal Analysis for Risk Factors
por: Charurat, Man, et al.
Publicado: (2010)

Immunological profile in persons under antiretroviral therapy in a rural Nigerian hospital
por: Musa, Baba Maiyaki, et al.
Publicado: (2010)

Prevalence and risk factors for obesity among elderly patients living with HIV/AIDS in a low-resource setting
por: Dakum, Patrick, et al.
Publicado: (2021)

Predictors of first-line antiretroviral therapy failure among adults and adolescents living with HIV/AIDS in a large prevention and treatment program in Nigeria
por: Ndembi, Nicaise, et al.
Publicado: (2020)

Prevalence of hypertension among patients aged 50 and older living with human immunodeficiency virus
por: Dakum, Patrick, et al.
Publicado: (2019)

Social barriers in accessing care by clients who returned to HIV care after transient loss to follow-up
por: Adelekan, Babatunde, et al.
Publicado: (2019)

Cost comparison of nine-month treatment regimens with 20-month standardized care for the treatment of rifampicin-resistant/multi-drug resistant tuberculosis in Nigeria
por: Bada, Florence O., et al.
Publicado: (2020)

Correction: Cost comparison of nine-month treatment regimens with 20-month standardized care for the treatment of rifampicin-resistant/multi-drug resistant tuberculosis in Nigeria
por: Bada, Florence O., et al.
Publicado: (2021)

A23 Identification of HIV drug resistance mutation patterns using illumina MiSeq next generation sequencing in patients failing second-line boosted protease inhibitor therapy in Nigeria
por: James, Onyemata E., et al.
Publicado: (2017)

Immuno-virologic outcomes and immuno-virologic discordance among adults alive and on anti-retroviral therapy at 12 months in Nigeria
por: Anude, Chuka J, et al.
Publicado: (2013)

Evaluation of accuracy and performance of self-reported HIV and antiretroviral therapy status in the Nigeria AIDS Indicator and Impact Survey (2018)
por: Jahun, Ibrahim, et al.
Publicado: (2022)

Disseminated infections due to Immune Reconstitution Inflammatory Syndrome after Highly Active Antiretroviral Therapy-Report of 3 cases from Nigeria
por: Ogoina, Dimie, et al.
Publicado: (2011)

Cost of three models of care for drug-resistant tuberculosis patients in Nigeria
por: Bada, Florence O., et al.
Publicado: (2019)

Missed opportunities for early infant diagnosis of HIV in rural North-Central Nigeria: A cascade analysis from the INSPIRE MoMent study
por: Anaba, Udochisom C., et al.
Publicado: (2019)

Characterisation of HIV-1 Molecular Epidemiology in Nigeria: Origin, Diversity, Demography and Geographic Spread
por: Nazziwa, Jamirah, et al.
Publicado: (2020)

Optimising Mycobacterium tuberculosis detection in resource limited settings
por: Alfred, Nwofor, et al.
Publicado: (2014)

Assuring the quality of diagnostic testing: The future is now
por: Nkengsong, John, et al.
Publicado: (2016)

Diagnostic system strengthening for drug resistant tuberculosis in Nigeria: impact and challenges
por: Aliyu, Gambo, et al.
Publicado: (2017)

Limited emergence of resistance to integrase strand transfer inhibitors (INSTIs) in ART-experienced participants failing dolutegravir-based antiretroviral therapy: a cross-sectional analysis of a Northeast Nigerian cohort
por: Abdullahi, Adam, et al.
Publicado: (2023)

Delay in the Provision of Antiretroviral Therapy to HIV-infected TB Patients in Nigeria
por: Odume, B., et al.
Publicado: (2017)

Hypertriglyceridemia in Antiretroviral Therapy
por: Imarhiagbe, Frank Aiwansoba, et al.
Publicado: (2005)

Initiation of antiretroviral therapy
por: Pandhi, Deepika, et al.
Publicado: (2014)

Individualization of antiretroviral therapy
por: Pavlos, Rebecca, et al.
Publicado: (2011)

Derivation of parameters used in Spectrum for eligibility for antiretroviral therapy and survival on antiretroviral therapy
por: Mahy, Mary, et al.
Publicado: (2010)

Performance and trend for quality of service in a large HIV/AIDS treatment program in Nigeria
por: Aliyu, Ahmad, et al.
Publicado: (2019)

Demography and the dual epidemics of tuberculosis and HIV: Analysis of cross-sectional data from Sub-Saharan Africa
por: Aliyu, Gambo, et al.
Publicado: (2018)

The role of connected diagnostics in strengthening regional, national and continental African disease surveillance
por: Gous, Natasha M., et al.
Publicado: (2018)

The cost of antiretroviral therapy in Haiti
por: Koenig, Serena P, et al.
Publicado: (2008)

When to Start Antiretroviral Therapy
por: Jain, Vivek, et al.
Publicado: (2010)

Optimizing adherence to antiretroviral therapy
por: Sahay, Seema, et al.
Publicado: (2011)

Measuring the Efficacy of Antiretroviral Therapy
por: Gude, Dilip
Publicado: (2012)

Cardiovascular Disease and Antiretroviral Therapy
por: Jarwani, Bhavesh
Publicado: (2019)

Growing old with antiretroviral therapy or elderly people in antiretroviral therapy: two different profiles of comorbidity?
por: Maggi, Paolo, et al.
Publicado: (2022)

Virological Response and Antiretroviral Drug Resistance Emerging during Antiretroviral Therapy at Three Treatment Centers in Uganda
por: Kaleebu, Pontiano, et al.
Publicado: (2015)

Cost-effectiveness of point-of-care digital chest-x-ray in HIV patients with pulmonary mycobacterial infections in Nigeria
por: Aliyu, Gambo, et al.
Publicado: (2014)

Chronic comorbidities in persons living with HIV within three years of exposure to antiretroviral therapy at Pantang Antiretroviral Center in Ghana: a retrospective study
por: Kotey, Martha, et al.
Publicado: (2022)

World Health Organization Dimensions of Adherence to Antiretroviral Therapy: A Study at Antiretroviral Therapy Centre, Aligarh
por: Alvi, Yasir, et al.
Publicado: (2019)

Client Satisfaction of Antiretroviral Therapy Service Delivery: A Cross-Sectional Study at an Antiretroviral Therapy Center
por: Nikitha, Origanti Sharon, et al.
Publicado: (2021)

Early Antiretroviral Therapy reduces the incidence of otorrhea in a randomized study of early and deferred antiretroviral therapy: Evidence from the Children with HIV Early Antiretroviral Therapy (CHER) Study
por: Hainline, Clotilde, et al.
Publicado: (2011)

Immunity in Nigerian women and the effects of pregnancy and infectious disease exposure on fetal immunity
por: Cairo, Cristiana, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_bsfsjhmf6e1ogb7clm4mu0u1s1